Bisphosphonate-related osteonecrosis of the jaw: specificities

  • Siri Paulo | sirivpaulo@gmail.com Faculty of Medicine, Coimbra University, Portugal.
  • Ana Margarida Abrantes Faculty of Medicine, Coimbra University, Portugal.
  • Mafalda Laranjo Faculty of Medicine, Coimbra University, Portugal.
  • Lina Carvalho Faculty of Medicine, Coimbra University, Portugal.
  • Arménio Serra Faculty of Science and Technology, Coimbra University, Portugal.
  • Maria Filomena Botelho Faculty of Medicine, Coimbra University, Portugal.
  • Manuel Marques Ferreira Faculty of Medicine, Coimbra University, Portugal.

Abstract

Bisphosphonate-related osteonecrosis of the jaws (BRONJ) is a severe complication that has recently emerged in patients treated with intravenous bisphosphonates for malignant diseases. This complication usually presents after a minor local trauma during a dental treatment. Several etiopathogenic mechanisms of this pathological condition have been proposed, but no model can explain all morphological changes observed at the macroscopic and microscopic level. BRONJ is likely to be related to direct toxicity in the bone and soft tissue cells, due to nitrogen-containing bisphosphonates. This review elucidates the clinical indications and mechanism of action of bisphosphonates, reports some clinical diagnostic criteria for BRONJ, describe the histopathological criteria for BRONJ diagnosis, the potential triggering pathways and the available treatment strategies.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Published
2014-09-23
Info
Issue
Section
Reviews
Keywords:
bone, bisphosphonate, osteonecrosis, jaw, soft tissues.
Statistics
  • Abstract views: 2568

  • PDF: 1030
  • HTML: 3406
How to Cite
Paulo, S., Abrantes, A. M., Laranjo, M., Carvalho, L., Serra, A., Botelho, M. F., & Ferreira, M. M. (2014). Bisphosphonate-related osteonecrosis of the jaw: specificities. Oncology Reviews, 8(2). https://doi.org/10.4081/oncol.2014.254